These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 10361121)

  • 1. Familial overexpression of beta antithrombin caused by an Asn135Thr substitution.
    Bayston TA; Tripodi A; Mannucci PM; Thompson E; Ireland H; Fitches AC; Hananeia L; Olds RJ; Lane DA
    Blood; 1999 Jun; 93(12):4242-7. PubMed ID: 10361121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Creation of an additional glycosylation site as a mechanism for type I antithrombin deficiency.
    Fitches AC; Lewandowski K; Olds RJ
    Thromb Haemost; 2001 Oct; 86(4):1023-7. PubMed ID: 11686319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antithrombin Murcia (K241E) causing antithrombin deficiency: a possible role for altered glycosylation.
    Martínez-Martínez I; Ordóñez A; Navarro-Fernández J; Pérez-Lara A; Gutiérrez-Gallego R; Giraldo R; Martínez C; Llop E; Vicente V; Corral J
    Haematologica; 2010 Aug; 95(8):1358-65. PubMed ID: 20435622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antithrombin Glasgow II: alanine 382 to threonine mutation in the serpin P12 position, resulting in a substrate reaction with thrombin.
    Ireland H; Lane DA; Thompson E; Walker ID; Blench I; Morris HR; Freyssinet JM; Grunebaum L; Olds R; Thein SL
    Br J Haematol; 1991 Sep; 79(1):70-4. PubMed ID: 1911389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Partial glycosylation of antithrombin III asparagine-135 is caused by the serine in the third position of its N-glycosylation consensus sequence and is responsible for production of the beta-antithrombin III isoform with enhanced heparin affinity.
    Picard V; Ersdal-Badju E; Bock SC
    Biochemistry; 1995 Jul; 34(26):8433-40. PubMed ID: 7599134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of the C-sheet in the maturation of N-glycans on antithrombin: functional relevance of pleiotropic mutations.
    Aguila S; Navarro-Fernández J; Bohdan N; Gutiérrez-Gallego R; de la Morena-Barrio ME; Vicente V; Corral J; Martínez-Martínez I
    J Thromb Haemost; 2014 Jul; 12(7):1131-40. PubMed ID: 24824609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New genetic variant in the SERPINC1 gene: hereditary Antithrombin deficiency case report, familial thrombosis and considerations on genetic counseling.
    Polyak ME; Zaklyazminskaya EV
    BMC Med Genet; 2020 Apr; 21(1):73. PubMed ID: 32252658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antithrombin III deficiency in Indian patients with deep vein thrombosis: identification of first India based AT variants including a novel point mutation (T280A) that leads to aggregation.
    Bhakuni T; Sharma A; Rashid Q; Kapil C; Saxena R; Mahapatra M; Jairajpuri MA
    PLoS One; 2015; 10(3):e0121889. PubMed ID: 25811371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Report of a novel kindred with antithrombin heparin-binding site variant (47 Arg to His): demand for an automated progressive antithrombin assay to detect molecular variants with low thrombotic risk.
    Rossi E; Chiusolo P; Za T; Marietti S; Ciminello A; Leone G; De Stefano V
    Thromb Haemost; 2007 Sep; 98(3):695-7. PubMed ID: 17849067
    [No Abstract]   [Full Text] [Related]  

  • 10. Antithrombins Wibble and Wobble (T85M/K): archetypal conformational diseases with in vivo latent-transition, thrombosis, and heparin activation.
    Beauchamp NJ; Pike RN; Daly M; Butler L; Makris M; Dafforn TR; Zhou A; Fitton HL; Preston FE; Peake IR; Carrell RW
    Blood; 1998 Oct; 92(8):2696-706. PubMed ID: 9763552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A novel mutation in antithrombin gene results in hereditary antithrombin deficiency].
    Zhang FH; Ding QL; Wu JS; Zhou RF; Wang XF; Xu XC
    Zhonghua Xue Ye Xue Za Zhi; 2006 Sep; 27(9):598-601. PubMed ID: 17278425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antithrombin III Nagasaki (Ser116-Pro): a heterozygous variant with defective heparin binding associated with thrombosis.
    Okajima K; Abe H; Maeda S; Motomura M; Tsujihata M; Nagataki S; Okabe H; Takatsuki K
    Blood; 1993 Mar; 81(5):1300-5. PubMed ID: 8443391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antithrombin deficiency in three Japanese families: one novel and two reported point mutations in the antithrombin gene.
    Maruyama K; Morishita E; Karato M; Kadono T; Sekiya A; Goto Y; Sato T; Nomoto H; Omi W; Tsuzura S; Imai H; Asakura H; Ohtake S; Nakao S
    Thromb Res; 2013 Aug; 132(2):e118-23. PubMed ID: 23809926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amelioration of the severity of heparin-binding antithrombin mutations by posttranslational mosaicism.
    Martínez-Martínez I; Navarro-Fernández J; Østergaard A; Gutiérrez-Gallego R; Padilla J; Bohdan N; Miñano A; Pascual C; Martínez C; de la Morena-Barrio ME; Aguila S; Pedersen S; Kristensen SR; Vicente V; Corral J
    Blood; 2012 Jul; 120(4):900-4. PubMed ID: 22498748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antithrombin Budapest 3. An antithrombin variant with reduced heparin affinity resulting from the substitution L99F.
    Olds RJ; Lane DA; Boisclair M; Sas G; Bock SC; Thein SL
    FEBS Lett; 1992 Apr; 300(3):241-6. PubMed ID: 1555650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel SERPINC1 missense mutation (Cys462Tyr) causes disruption of the 279Cys-462Cys disulfide bond and leads to type Ⅰ hereditary antithrombin deficiency.
    Zhang F; Gui Y; Lu Y; Liu D; Chen H; Qin X; Li S
    Clin Biochem; 2020 Nov; 85():38-42. PubMed ID: 32745482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A heparin binding site Arg79Cys missense mutation in the SERPINC1 gene in a Korean patient with hereditary antithrombin deficiency.
    Yoo JH; Maeng HY; Kim HJ; Lee KA; Choi JR; Song J
    Ann Clin Lab Sci; 2011; 41(1):89-92. PubMed ID: 21325262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antithrombin Dublin (p.Val30Glu): a relatively common variant with moderate thrombosis risk of causing transient antithrombin deficiency.
    Navarro-Fernández J; de la Morena-Barrio ME; Padilla J; Miñano A; Bohdan N; Águila S; Martínez-Martínez I; Sevivas TS; de Cos C; Fernández-Mosteirín N; Llamas P; Asenjo S; Medina P; Souto JC; Overvad K; Kristensen SR; Corral J; Vicente V
    Thromb Haemost; 2016 Jul; 116(1):146-54. PubMed ID: 27098529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antithrombin deficiency due to heterozygous antithrombin gene mutation and a pedigree study].
    Ye X; Feng Y; Jin PP; Zhou XH; Ding QL; Wang XF
    Zhonghua Xue Ye Xue Za Zhi; 2007 Sep; 28(9):587-9. PubMed ID: 18246812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antithrombin Nagasaki (Ser 116 to Pro): a rare antithrombin variant with abnormal heparin binding presenting during pregnancy.
    O'Ddonnell JS; Hinkson L; McCarthy A; Manning R; Khan A; Laffan MA
    Blood Coagul Fibrinolysis; 2006 Apr; 17(3):217-20. PubMed ID: 16575261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.